Michael Steinman, MD, professor of medicine, University of California, San Diego, discusses effective strategies for improving medication management for patients and how these strategies can improve outcomes, such as medication adherence.
Michael Steinman, MD, professor of medicine, University of California, San Diego, discusses effective strategies for improving medication management for patients and how these strategies can improve outcomes, such as medication adherence.
Transcript
What are some strategies that can effectively improve medication management for patients?
There’s a lot of different strategies that can improve medication management, and I think one of the key things is that there’s a huge spectrum. So, one of the challenges is that patients need education, so some strategies can improve education. There’s some strategies of care coordination between physicians, there’s issues of prescribing inappropriate or appropriate medications and how can we disincentivize the inappropriate ones and incentivize the appropriate ones through a systems approach. There’s issues of patient engagement and empowerment, so there’s this huge gamut of issues, and it’s unlikely that any single intervention will affect all of them, but I think the mistake we sometimes make is focusing on just 1 and ignoring the others because it’s only attacking one small piece of the puzzle, and it’s really kind of helping with multiple different elements and having them all line up that’s ultimately going to make the biggest difference. We can’t do it all at once, but we should keep in mind the big picture even while we’re trying to slice off one particular part.
How do these management strategies improve outcomes like medication adherence and, in turn, improve patient outcomes?
The ultimate goal, of course, is improving patient outcomes, and in some cases that could be getting patients to adhere better to their medications, which are helpful and indicated for them. In some cases, it could be getting patients to stop adhering to their medications, stopping medications that are harmful or unnecessary for them. So, it’s really right sizing the medications, and so part of the strategy is really understanding, first of all, where patients are at, what they’re taking, how adherent they are, why they might be adherent or not adherent, what are some of the barriers and facilitators, and addressing those.
And again, it gets back to the issue of being smart about it. So, we shouldn’t be promoting adherence to medications which really are note necessary or may be excessively costly when there’s a cheaper and maybe easier to take alternative. At the same time, we should be thinking about increasing understanding of patients’ experience of medications and the reasons they’re really taking them so we can stop or avoid medications which aren’t necessary. Particularly for older adults, overuse of medication is very common, and we could probably improve outcomes a lot by stopping those meds.
One final point is that we should really be thinking about outcomes in terms of patient-centered outcomes. Hemoglobin A1c is not an outcome. Blood pressure is not an outcome. Strokes, quality of life, death, things like that, those are the outcomes we should be keeping our eyes on.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More